ACTIVE INGREDIENT
ACTIVE INGREDIENTS: NIACINAMIDE (2.00%)
ACTIVE INGREDIENTS: NIACINAMIDE (2.00%)
INACTIVE INGREDIENTS: SACCHAROMYCES FERMENT,GLYCERIN,DIPROPYLENE GLYCOL,CYCLOMETHICONE,CETEARYL ALCOHOL,TRIETHYLHEXANOIN,BUTYROSPERMUM PARKII (SHEA) BUTTER,1,2-HEXANEDIOL,HYDROGENATED POLY(C6-14 OLEFIN),CETEARYL GLUCOSIDE,CAPRYLIC/CAPRIC TRIGLYCERIDE,GLYCERYL STEARATE SE,PIPER METHYSTICUM LEAF/ROOT/STEM EXTRACT,GLYCERYL STEARATE,C12-16 ALCOHOLS,ARCTIUM LAPPA ROOT EXTRACT,DIMETHICONE,PEG-100 STEARATE,PHELLINUS LINTEUS EXTRACT,HYDROGENATED LECITHIN,SOLUBLE COLLAGEN,BETAINE,MICROCRYSTALLINE CELLULOSE,SQUALANE,WATER,PALMITIC ACID,PORTULACA OLERACEA EXTRACT,PUERARIA THUNBERGIANA ROOT EXTRACT,CNIDIUM OFFICINALE ROOT EXTRACT,GLYCYRRHIZA GLABRA (LICORICE) ROOT EXTRACT,PAEONIA LACTIFLORA ROOT EXTRACT,CETYL ALCOHOL,BISABOLOL,CITRUS AURANTIUM DULCIS (ORANGE) FRUIT WATER,POLYSORBATE 60,ALOE BARBADENSIS LEAF EXTRACT,HIBISCUS ESCULENTUS FRUIT EXTRACT,LINUM USITATISSIMUM (LINSEED) SEED EXTRACT,ALTHAEA OFFICINALIS LEAF/ROOT EXTRACT,ANTHEMIS NOBILIS FLOWER EXTRACT,FOENICULUM VULGARE (FENNEL) LEAF EXTRACT,HOUTTUYNIA CORDATA EXTRACT,OCIMUM BASILICUM (BASIL) FLOWER/LEAF EXTRACT,CENTELLA ASIATICA EXTRACT,CALENDULA OFFICINALIS FLOWER EXTRACT,ALOE BARBADENSIS LEAF JUICE,CELLULOSE GUM,CITRUS GRANDIS (GRAPEFRUIT) PEEL OIL,PEG-75 STEARATE,ARGANIA SPINOSA KERNEL OIL,OLEA EUROPAEA (OLIVE) FRUIT OIL,CETETH-20,STEARETH-20,DISODIUM EDTA,ETHYLHEXYLGLYCERIN,CITRUS AURANTIFOLIA (LIME) OIL,SODIUM HYALURONATE,DICAPRYLYL CARBONATE,CETEARYL OLIVATE,HYDROXYETHYL ACRYLATE/SODIUM ACRYLOYLDIMETHYL TAURATE COPOLYMER,SORBITAN OLIVATE,BUTYLENE GLYCOL,SUCROSE DISTEARATE,RIBES NIGRUM (BLACK CURRANT) SEED OIL,CERAMIDE 3,XANTHAN GUM,ROSE FLOWER OIL,ILLICIUM VERUM (ANISE) FRUIT/SEED OIL,FOLIC ACID,CHOLESTEROL,RAFFINOSE,HYDROGENATED POLYDECENE,PHOSPHOLIPIDS,PHYTOSPHINGOSINE,TROMETHAMINE,CERAMIDE 2,PALMITOYL PENTAPEPTIDE-4,PANTHENOL
PURPOSE: [BRIGTHENING] This eye cream with the skin brightening function makes the skin around the eyes clear and transparent.
CAUTIONS: 1. For external use only 2. Avoid contact with eyes and mouth 3. Discontinue us if signs of irritation or rashes appear 4. Keep out of reach of children 5. Replace the cap after use
KEEP OUT OF REACH OF CHILDREN
HOW TO USE: Take a small amount and gently pat around the area of your eyes as the last step in your skincare routine.
HOW TO USE: Take a small amount and gently pat around the area of your eyes as the last step in your skincare routine.
| Resource | Code type | Value | Equivalent identifiers | Source image |
|---|---|---|---|---|
| Barcode | EAN-13 | 8806173416691 | GTIN-13: 8806173416691 EAN-13: 8806173416691 GTIN storage (14 digits): 08806173416691 | saccharomyces the first eye cream carton.jpg |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| NIACINAMIDE | ACTIVE INGREDIENT | 25X51I8RD4 | 1 | |
| NIACINAMIDE | ACTIVE MOIETY | 25X51I8RD4 | 1 | |
| DIPROPYLENE GLYCOL | INACTIVE INGREDIENT | E107L85C40 | 1 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 51346-333 | 51346-333-01 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| NIACINAMIDE | 25X51I8RD4 | ACTIB |
| GLYCERIN | PDC6A3C0OX | IACT |
| DIPROPYLENE GLYCOL | E107L85C40 | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET, FILM COATED / ORAL | 1.55 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION / AURICULAR (OTIC) | 0.05 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUPPOSITORY / VAGINAL | 227.9 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | OINTMENT / TOPICAL | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET, COATED / ORAL | 1 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / INTRAVENOUS | 33750 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / NASAL | 25 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION/ DROPS / ORAL | 750 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | LOTION / TOPICAL | 3990 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | AEROSOL / TOPICAL | 3 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 225 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | DROPS / NASAL | 10 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET / PERIODONTAL | 0.53 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE, LIQUID FILLED / ORAL | 185 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SPONGE / TOPICAL | 2 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CREAM / TOPICAL | 1720 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET, CHEWABLE / ORAL | 12 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | FILM, EXTENDED RELEASE / BUCCAL | 34 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | MOUTHWASH / BUCCAL | 100 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CREAM / VAGINAL | 60 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | JELLY / VAGINAL | NA | ||
| DIPROPYLENE GLYCOL | DIPROPYLENE GLYCOL | E107L85C40 | SYSTEM / TRANSDERMAL | 6 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE / ORAL | 3487 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET / ORAL | 42 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GEL / TOPICAL | 500 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / INTRAVENOUS | 15 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SHAMPOO / TOPICAL | 5 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GEL / TRANSDERMAL | 500 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | LIQUID / ORAL | 2400 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / INTRAMUSCULAR | 450 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / TOPICAL | 1971 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | JELLY / TOPICAL | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / ORAL | 32400 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION, CONCENTRATE / ORAL | 200 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SPRAY, METERED / NASAL | 13 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE, COATED / ORAL | 14.21 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION/ DROPS / AURICULAR (OTIC) | 25 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION / OPHTHALMIC | 58 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GEL / OPHTHALMIC | 0.88 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / SUBCUTANEOUS | 15 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CREAM, AUGMENTED / TOPICAL | 55 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / AURICULAR (OTIC) | 63.64 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | FILM, EXTENDED RELEASE / TRANSDERMAL | 306.2 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET, EXTENDED RELEASE / ORAL | 7 mg | ||
| DIPROPYLENE GLYCOL | DIPROPYLENE GLYCOL | E107L85C40 | FILM, EXTENDED RELEASE / TRANSDERMAL | 296 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / RESPIRATORY (INHALATION) | 5 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | ELIXIR / ORAL | 5621 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | DOUCHE / VAGINAL | 1 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CLOTH / TOPICAL | 0.05 mg/mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | DROPS / ORAL | 300 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | PASTE, DENTIFRICE / DENTAL | 18 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | PASTE / ORAL | 3822 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | PASTE / DENTAL | 20 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION, EXTENDED RELEASE / ORAL | 2000 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SYRUP / ORAL | 16734 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SPRAY / NASAL | 22.3 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CONCENTRATE / ORAL | 1800 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, SUSPENSION / SUBCUTANEOUS | 1.6 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOAP / TOPICAL | 0.76 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION/ DROPS / OPHTHALMIC | 12 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| d8005639-b8e3-4f34-a196-f600ceaee315 | 6a39e02b-b9c4-4241-9905-2ed5a71ba160 | 2021-07-05 | Warnings | 6a39e02b-b9c4-4241-9905-2ed5a71ba160 |
Adverse event summaries are temporarily unavailable. Other product information remains available.